P31645 SC6A4_HUMAN
Gene name: SLC6A4
Protein name: Sodium-dependent serotonin transporter
List of molecules and drugs that target protein P31645
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P31645_DB00176 | DB00176 | Fluvoxamine | inhibitor | CJOFXWAVKWHTFT-XSFVSMFZSA-N | COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F | |
2 | P31645_DB00182 | DB00182 | Amphetamine | binder | KWTSXDURSIMDCE-UHFFFAOYSA-N | CC(N)CC1=CC=CC=C1 | |
3 | P31645_DB00191 | DB00191 | Phentermine | inhibitor | DHHVAGZRUROJKS-UHFFFAOYSA-N | CC(C)(N)CC1=CC=CC=C1 | |
4 | P31645_DB00193 | DB00193 | Tramadol | inhibitor | IC50(nM) = 1100.0 | TVYLLZQTGLZFBW-UHFFFAOYSA-N | COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C |
5 | P31645_DB00215 | DB00215 | Citalopram | inhibitor | Ki(nM) = 0.78 IC50(nM) = 3.0 EC50(nM) = 8700.0 | WSEQXVZVJXJVFP-UHFFFAOYSA-N | CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1 |
6 | P31645_DB00245 | DB00245 | Benzatropine | inhibitor | IC50(nM) = 24100.0 | GIJXKZJWITVLHI-PMOLBWCYSA-N | [H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C |
7 | P31645_DB00285 | DB00285 | Venlafaxine | inhibitor | Ki(nM) = 7.5 IC50(nM) = 20.0 Kd(nM) = 8.9 | PNVNVHUZROJLTJ-UHFFFAOYSA-N | COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1 |
8 | P31645_DB00289 | DB00289 | Atomoxetine | binder | IC50(nM) = 48.0 Kd(nM) = 8.9 | VHGCDTVCOLNTBX-QGZVFWFLSA-N | CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1 |
9 | P31645_DB00321 | DB00321 | Amitriptyline | inhibitor | Ki(nM) = 2.8 | KRMDCWKBEZIMAB-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
10 | P31645_DB00344 | DB00344 | Protriptyline | inhibitor | Ki(nM) = 19.6 | BWPIARFWQZKAIA-UHFFFAOYSA-N | CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12 |
11 | P31645_DB00408 | DB00408 | Loxapine | binder | XJGVXQDUIWGIRW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2 | |
12 | P31645_DB00454 | DB00454 | Meperidine | binder | XADCESSVHJOZHK-UHFFFAOYSA-N | CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1 | |
13 | P31645_DB00458 | DB00458 | Imipramine | inhibitor | Ki(nM) = 0.15 IC50(nM) = 0.88 | BCGWQEUPMDMJNV-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
14 | P31645_DB00472 | DB00472 | Fluoxetine | inhibitor | Ki(nM) = 0.72 IC50(nM) = 2.5 Kd(nM) = 0.81 EC50(nM) = 2.7 | RTHCYVBBDHJXIQ-UHFFFAOYSA-N | CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1 |
15 | P31645_DB00476 | DB00476 | Duloxetine | inhibitor | Ki(nM) = 0.2 IC50(nM) = 0.316228 | ZEUITGRIYCTCEM-KRWDZBQOSA-N | CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1 |
16 | P31645_DB00514 | DB00514 | Dextromethorphan | inhibitor | MKXZASYAUGDDCJ-NJAFHUGGSA-N | [H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2 | |
17 | P31645_DB00540 | DB00540 | Nortriptyline | inhibitor | Ki(nM) = 15.0 | PHVGLTMQBUFIQQ-UHFFFAOYSA-N | CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
18 | P31645_DB00543 | DB00543 | Amoxapine | inhibitor | Ki(nM) = 58.0 | QWGDMFLQWFTERH-UHFFFAOYSA-N | ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1 |
19 | P31645_DB00574 | DB00574 | Fenfluramine | substrate | DBGIVFWFUFKIQN-UHFFFAOYSA-N | CCNC(C)CC1=CC=CC(=C1)C(F)(F)F | |
20 | P31645_DB00579 | DB00579 | Mazindol | inhibitor | Ki(nM) = 45.0 IC50(nM) = 54.0 | ZPXSCAKFGYXMGA-UHFFFAOYSA-N | OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1 |
21 | P31645_DB00656 | DB00656 | Trazodone | inhibitor | Ki(nM) = 160.0 | PHLBKPHSAVXXEF-UHFFFAOYSA-N | ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1 |
22 | P31645_DB00661 | DB00661 | Verapamil | unknown | SGTNSNPWRIOYBX-UHFFFAOYSA-N | COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1 | |
23 | P31645_DB00715 | DB00715 | Paroxetine | inhibitor | Ki(nM) = 0.04 IC50(nM) = 0.2 Kd(nM) = 0.13 | AHOUBRCZNHFOSL-YOEHRIQHSA-N | FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1 |
24 | P31645_DB00726 | DB00726 | Trimipramine | inhibitor | Ki(nM) = 149.0 | ZSCDBOWYZJWBIY-UHFFFAOYSA-N | CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12 |
25 | P31645_DB00805 | DB00805 | Minaprine | inhibitor | LDMWSLGGVTVJPG-UHFFFAOYSA-N | CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1 | |
26 | P31645_DB00852 | DB00852 | Pseudoephedrine | inhibitor | KWGRBVOPPLSCSI-WCBMZHEXSA-N | CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 | |
27 | P31645_DB00907 | DB00907 | Cocaine | inhibitor | Ki(nM) = 155.0 IC50(nM) = 270.0 EC50(nM) = 318.0 | ZPUCINDJVBIVPJ-LJISPDSOSA-N | [H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C |
28 | P31645_DB00924 | DB00924 | Cyclobenzaprine | inhibitor | JURKNVYFZMSNLP-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12 | |
29 | P31645_DB00988 | DB00988 | Dopamine | inhibitor | Ki(nM) = 1100000.0 IC50(nM) = 30000.0 | VYFYYTLLBUKUHU-UHFFFAOYSA-N | NCCC1=CC(O)=C(O)C=C1 |
30 | P31645_DB01104 | DB01104 | Sertraline | inhibitor | IC50(nM) = 0.19 Kd(nM) = 0.29 | VGKDLMBJGBXTGI-SJCJKPOMSA-N | CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12 |
31 | P31645_DB01105 | DB01105 | Sibutramine | inhibitor | UNAANXDKBXWMLN-UHFFFAOYSA-N | CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1 | |
32 | P31645_DB01114 | DB01114 | Chlorpheniramine | inhibitor | SOYKEARSMXGVTM-UHFFFAOYSA-N | CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 | |
33 | P31645_DB01142 | DB01142 | Doxepin | inhibitor | ODQWQRRAPPTVAG-UHFFFAOYSA-N | [H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12 | |
34 | P31645_DB01149 | DB01149 | Nefazodone | inhibitor | Ki(nM) = 200.0 Kd(nM) = 200.0 | VRBKIVRKKCLPHA-UHFFFAOYSA-N | CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1 |
35 | P31645_DB01151 | DB01151 | Desipramine | inhibitor | Ki(nM) = 17.6 IC50(nM) = 64.0 | HCYAFALTSJYZDH-UHFFFAOYSA-N | CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
36 | P31645_DB01175 | DB01175 | Escitalopram | inhibitor | Ki(nM) = 1.0 IC50(nM) = 2.1 Kd(nM) = 2.6 EC50(nM) = 5100.0 | WSEQXVZVJXJVFP-FQEVSTJZSA-N | CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1 |
37 | P31645_DB01191 | DB01191 | Dexfenfluramine | inhibitor | DBGIVFWFUFKIQN-VIFPVBQESA-N | CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F | |
38 | P31645_DB01238 | DB01238 | Aripiprazole | modulator | Ki(nM) = 32.0 | CEUORZQYGODEFX-UHFFFAOYSA-N | ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl |
39 | P31645_DB01242 | DB01242 | Clomipramine | inhibitor | Ki(nM) = 0.05 IC50(nM) = 70.0 | GDLIGKIOYRNHDA-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2 |
40 | P31645_DB01442 | DB01442 | MMDA | negative modulator | YQYUWUKDEVZFDB-UHFFFAOYSA-N | COC1=CC(CC(C)N)=CC2=C1OCO2 | |
41 | P31645_DB01454 | DB01454 | Midomafetamine | negative modulator | Ki(nM) = 0.73 IC50(nM) = 384.0 EC50(nM) = 1000.0 | SHXWCVYOXRDMCX-UHFFFAOYSA-N | CNC(C)CC1=CC2=C(OCO2)C=C1 |
42 | P31645_DB01472 | DB01472 | 4-Methoxyamphetamine | inhibitor | NEGYEDYHPHMHGK-UHFFFAOYSA-N | COC1=CC=C(CC(C)N)C=C1 | |
43 | P31645_DB01577 | DB01577 | Metamfetamine | negative modulator | MYWUZJCMWCOHBA-VIFPVBQESA-N | CN[C@@H](C)CC1=CC=CC=C1 | |
44 | P31645_DB04821 | DB04821 | Nomifensine | n/a | Ki(nM) = 874.0 | XXPANQJNYNUNES-UHFFFAOYSA-N | CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2 |
45 | P31645_DB04832 | DB04832 | Zimelidine | n/a | OYPPVKRFBIWMSX-SXGWCWSVSA-N | CN(C)C\C=C(\C1=CC=C(Br)C=C1)C1=CC=CN=C1 | |
46 | P31645_DB04836 | DB04836 | Amineptine | n/a | ONNOFKFOZAJDHT-UHFFFAOYSA-N | OC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12 | |
47 | P31645_DB04889 | DB04889 | Bicifadine | n/a | IC50(nM) = 117.0 | OFYVIGTWSQPCLF-UHFFFAOYSA-N | CC1=CC=C(C=C1)C12CC1CNC2 |
48 | P31645_DB04896 | DB04896 | Milnacipran | inhibitor | Ki(nM) = 8.44 IC50(nM) = 64.0 | GJJFMKBJSRMPLA-UHFFFAOYSA-N | CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1 |
49 | P31645_DB05422 | DB05422 | OPC-14523 | n/a | TZZGTNZBLPCBIS-UHFFFAOYSA-N | COC1=CC=CC2=C1CCC(=O)N2CCCN1CCN(CC1)C1=CC=CC(Cl)=C1 | |
50 | P31645_DB05964 | DB05964 | Amitifadine | n/a | BSMNRYCSBFHEMQ-KCJUWKMLSA-N | [H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1 | |
51 | P31645_DB06077 | DB06077 | Lumateperone | inhibitor | HOIIHACBCFLJET-SFTDATJTSA-N | [H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C | |
52 | P31645_DB06148 | DB06148 | Mianserin | inhibitor | UEQUQVLFIPOEMF-UHFFFAOYSA-N | CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21 | |
53 | P31645_DB06156 | DB06156 | Tesofensine | n/a | VCVWXKKWDOJNIT-ZOMKSWQUSA-N | CCOC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C | |
54 | P31645_DB06204 | DB06204 | Tapentadol | inhibitor | KWTWDQCKEHXFFR-SMDDNHRTSA-N | CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1 | |
55 | P31645_DB06684 | DB06684 | Vilazodone | inhibitor | Ki(nM) = 0.5 IC50(nM) = 0.4 | SGEGOXDYSFKCPT-UHFFFAOYSA-N | NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1 |
56 | P31645_DB06700 | DB06700 | Desvenlafaxine | inhibitor | Ki(nM) = 4.1 IC50(nM) = 53.0 | KYYIDSXMWOZKMP-UHFFFAOYSA-N | CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1 |
57 | P31645_DB06701 | DB06701 | Dexmethylphenidate | inhibitor | DUGOZIWVEXMGBE-CHWSQXEVSA-N | [H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1 | |
58 | P31645_DB08839 | DB08839 | Serotonin | n/a | QZAYGJVTTNCVMB-UHFFFAOYSA-N | NCCC1=CNC2=CC=C(O)C=C12 | |
59 | P31645_DB08918 | DB08918 | Levomilnacipran | inhibitor | IC50(nM) = 320.0 | GJJFMKBJSRMPLA-DZGCQCFKSA-N | CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1 |
60 | P31645_DB09068 | DB09068 | Vortioxetine | inhibitor | YQNWZWMKLDQSAC-UHFFFAOYSA-N | CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1 | |
61 | P31645_DB09167 | DB09167 | Dosulepin | inhibitor | PHTUQLWOUWZIMZ-GZTJUZNOSA-N | CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12 | |
62 | P31645_DB09186 | DB09186 | Nisoxetine | n/a | Ki(nM) = 30.0 IC50(nM) = 20.0 | ITJNARMNRKSWTA-UHFFFAOYSA-N | CNCCC(OC1=CC=CC=C1OC)C1=CC=CC=C1 |
63 | P31645_DB09195 | DB09195 | Lorpiprazole | antagonist | BNRMWKUVWLKDQJ-YJBOKZPZSA-N | [H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2 | |
64 | P31645_DB09225 | DB09225 | Zotepine | antagonist | Ki(nM) = 1000.0 | HDOZVRUNCMBHFH-UHFFFAOYSA-N | CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12 |
65 | P31645_DB12305 | DB12305 | Dasotraline | n/a | SRPXSILJHWNFMK-MEDUHNTESA-N | N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12 |